EKSO Q2 2023 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5M+35.7% YoY

Gross Profit

$2M47.9% margin

Operating Income

-$4M-91.1% margin

Net Income

-$4M-89.9% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$640,000

Balance Sheet

Total Assets

$34M

Total Liabilities

$16M

Stockholders' Equity

$18M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+35.7%
Gross Profit	$2M	$2M	+37.4%
Operating Income	-$4M	-$3M	-32.7%
Net Income	-$4M	-$3M	-42.0%

Geographic Segments

Americas

$4M39%

UNITED STATES

$4M39%

EMEA

$863,0009%

ROMANIA

$475,0005%

POLAND

$284,0003%

Asia Pacific

$150,0002%

HONG KONG

$118,0001%

EMEA Other

$104,0001%

APAC Other

$32,0000%

Americas Other

$6,0000%